PhD in Internal Medicine

Dalian Medical University (DMU), established in 1947 in the coastal city of Dalian, is one of China’s long-standing medical institutions, offering medicine, dentistry, nursing and allied health programs. With about 14,000 students and roughly 1,300 international students, DMU operates modern teaching and research facilities alongside multiple affiliated hospitals to provide clinically focused education and extensive practical experience.

DMU was among the early Chinese universities to offer MBBS programs in English and its medical degrees are recognized internationally. The university maintains state-of-the-art laboratories, a comprehensive library and three affiliated hospitals with significant bed capacity, ensuring hands-on clinical training and research exposure. DMU offers a wide portfolio of programs across health and related disciplines to prepare graduates for global medical careers.

Campus life is calm and study-oriented, with two main campuses, student clubs, exchange opportunities and support services for international students. On-campus apartments for international students are fully equipped and cost an estimated 11,000 RMB per year, while off-campus options vary by budget and location. For aspiring clinicians and health researchers, DMU combines rigorous training, hospital partnerships and a livable coastal setting to support professional development.

The PhD in Internal Medicine at Dalian Medical University is a 3-year degree for students who want to become experts in internal medicine. It's taught in English and is for students who have finished high school.

This program will help you learn about cardiology, gastroenterology, and nephrology. You'll also get to practice your skills in a clinical setting and work on research projects to help you become a skilled doctor.

After graduating, you can work as a Cardiologist, Gastroenterologist, or Nephrologist. You can also work in hospitals, clinics, or research centers, helping people with internal medicine problems and finding new treatments.